CanSino Biologics Inc Strategic Asset Allocation Index
CanSino Biologics Inc strategic asset allocation index. CanSino Biologics Inc (CJH) has a Strategic Asset Allocation Index of 47.8% as of June 2023. Strategic assets (PP&E of €2.85 Billion plus long-term investments of €-) total €2.85 Billion, measured against net assets of €5.97 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CanSino Biologics Inc (CJH) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of CanSino Biologics Inc (2016–2022)
Strategic asset allocation index of CanSino Biologics Inc from 2016 to 2022. This chart shows how CanSino Biologics Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 47.8%, representing strategic assets of €2.85 Billion against net assets of €5.97 Billion EUR. Check CJH tangible net assets ratio to evaluate the tangible quality of the company's equity base.
CanSino Biologics Inc Strategic Asset Allocation Index by Year (2016–2022)
CanSino Biologics Inc strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for CanSino Biologics Inc from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CJH company net worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 42.4% | €3.07 Billion | €3.07 Billion | €- | €7.25 Billion | ▲ +16.4 pp |
| 2021 | 26.0% | €2.22 Billion | €2.22 Billion | €- | €8.55 Billion | ▲ +11.6 pp |
| 2020 | 14.4% | €873.95 Million | €873.95 Million | €- | €6.07 Billion | ▼ -24.7 pp |
| 2019 | 39.1% | €574.89 Million | €574.89 Million | €- | €1.47 Billion | ▼ -61.9 pp |
| 2018 | 101.0% | €507.45 Million | €507.45 Million | €- | €502.32 Million | ▲ +35.7 pp |
| 2017 | 65.4% | €396.89 Million | €396.89 Million | €- | €607.33 Million | ▼ -8.4 pp |
| 2016 | 73.8% | €158.18 Million | €158.18 Million | €- | €214.47 Million | — |